Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medisen is a South Korean medical technology company specializing in advanced drug delivery systems and medical devices. The company is best known for its Handy-G platform, a digital drug delivery system designed for precise, automated injections in dermatology and aesthetic medicine. Medisen focuses on integrating electronic control technology with pharmaceutical applications to improve the efficacy and safety of localized treatments. Their research extends into treatments for alopecia and skin regeneration, utilizing proprietary technology to enhance transdermal absorption. The company operates a dedicated Medical Technology Research Institute to drive innovation in minimally invasive medical procedures. Medisen's products are primarily targeted at the global aesthetic and clinical dermatology markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEDISEN Medical Technology Research.